Correction to: Nature Immunology https://doi.org/10.1038/s41590-019-0441-y, published online 29 July 2019.
In the version of this article initially published, the information for affiliation 11 was incomplete. The correct, full affiliation is as follows: The Loop Immuno-Oncology Laboratory, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA. The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Verma, V., Shrimali, R.K., Ahmad, S. et al. Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance. Nat Immunol 20, 1555 (2019). https://doi.org/10.1038/s41590-019-0519-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-019-0519-6
This article is cited by
-
A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy
Nature Nanotechnology (2022)
-
A cascade targeting strategy based on modified bacterial vesicles for enhancing cancer immunotherapy
Journal of Nanobiotechnology (2021)
